Open-label, multicenter phase 1/2 dose escalation and expansion study of THOR-707 as a single agent and in combination with a PD-1 inhibitor in adult subjects with advanced or metastatic solid tumors Conference Paper uri icon

authors

  • Luo, David
  • Abdul-Karim, Raghad
  • Azad, Arun
  • Bendell, Joanna
  • Gan, Hui
  • Janku, Filip
  • Sen, Shiraj
  • Tan, Tira
  • Wang, Judy
  • Schechet, Lisa
  • Baker, Lauren
  • Leveque, Joseph
  • Meniawy, Tarek

publication date

  • November 6, 2019